← Back to Search

Herbal Extract

Gel capsule for Attention Deficit Disorder

N/A
Waitlist Available
Led By Dawn Beckman, MD
Research Sponsored by PepsiCo Global R&D
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-dose baseline to 60 minutes and 120 minutes post-guayusa consumption compared to placebo
Awards & highlights

Study Summary

This trial is assessing the effects of guayusa on alertness and mental fatigue compared to a placebo, using the COMPASS cognitive task, CDB, and mood, motivation, and energy measures.

Eligible Conditions
  • Attention Deficit Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-dose baseline to 60 minutes and 120 minutes post-guayusa consumption compared to placebo
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre-dose baseline to 60 minutes and 120 minutes post-guayusa consumption compared to placebo for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Other outcome measures
Cognitive Testing
Cognitive memory test: Words
Cognitive test RVIP
+5 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Active capsule 2: Higher dose guayusa ingredientExperimental Treatment1 Intervention
Oral administration of 300 mg guayusa extract providing 60 mg caffeine
Group II: Active capsule 1: Lower dose guayusa ingredientExperimental Treatment1 Intervention
Oral administration of 175 mg guayusa extract providing 35 mg caffeine
Group III: Placebo capsulePlacebo Group1 Intervention
Oral administration of 0 mg guayusa extract, 0 mg caffeine. Capsule color-matched to actives 1 and 2 to disguise potential differences in color of contents.

Find a Location

Who is running the clinical trial?

PepsiCo Global R&DLead Sponsor
89 Previous Clinical Trials
12,601 Total Patients Enrolled
Dawn Beckman, MDPrincipal InvestigatorMérieux NutriSciences
8 Previous Clinical Trials
425 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~22 spots leftby Apr 2025